衰弱合并心血管疾病的研究进展

doi:10.3969/j.issn.1003-9198.2023.01.019

[1] 《中国心血管健康与疾病报告》编写组. 《中国心血管健康与疾病报告2020》要点解读[J].中国心血管杂志,2021,26(3):10.
[2] AFILALO J, ALEXANDER K P, MACK M J, et al. Frailty assessment in the cardiovascular care of older adults[J]. J Am Coll Cardiol, 2014, 63(8): 747-762.
[3] AFILALO J, KARUNANANTHAN S, EISENBERG M J, et al. Role of frailty in patients with cardiovascular disease[J]. Am J Cardiol, 2009, 103(11): 1616-1621.
[4] CLEGG A, YOUNG J, ILIFFE S, et al. Frailty in elderly people[J]. Lancet, 2013, 381(9868): 752-762.
[5] NEWMAN A B, GOTTDIENER J S, MCBURNIE M A, et al. Associations of subclinical cardiovascular disease with frailty[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3): 158-166.
[6] VETRANO D L, PALMER K M, GALLUZZO L, et al. Hypertension and frailty: a systematic review and meta-analysis[J]. BMJ Open, 2018, 8(12): e024406.
[7] MA L, ZHANG L, SUN F, et al. Frailty in Chinese older adults with hypertension: prevalence, associated factors, and prediction for long-term mortality[J]. J Clin Hypertens: Greenwich, 2018, 20(11): 1595-1602.
[8] DAMLUJI A A, CHUNG S E, XUE Q L, et al. Physical frailty phenotype and the development of geriatric syndromes in older adults with coronary heart disease[J]. Am J Med, 2020, 134(5): 662-671.
[9] BEBB O, SMITH F G, CLEGG A, et al. Frailty and acute coronary syndrome: a structured literature review[J]. Eur Heart J Acute Cardiovasc Care, 2018, 7(2): 166-175.
[10] SINGH M, RIHAL C S, LENNON R J, et al. Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization[J]. Circ Cardiovasc Qual Outcomes, 2011, 4(5): 496-502.
[11] MURALI-KRISHNAN R, IQBAL J, ROWE R, et al. Impact of frailty on outcomes after percutaneous coronary intervention: a prospective cohort study[J]. Open heart, 2015, 2(1): e000294.
[12] VILLANI E R, TUMMOLO A M, PALMER K, et al. Frailty and atrial fibrillation: a systematic review[J]. Eur J Intern Med, 2018, 56: 33-38.
[13] SON Y J, LEE K, KIM B H. Gender differences in the association between frailty, cognitive impairment, and self-care behaviors among older adults with atrial fibrillation[J]. Int J Environ Res Public Health, 2019, 16(13): 2387.
[14] PERERA V, BAJOREK B V, MATTHEWS S, et al. The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation[J]. Age Ageing, 2009, 38(2): 156-162.
[15] NGUYEN T N, CUMMING R G, HILMER S N. Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail[J]. Intern Med J, 2016, 46(1): 86-95.
[16] MADHAVAN M, HOLMES D N, PICCINI J P, et al. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation[J]. Am Heart J, 2019, 211(5): 77-89.
[17] OQAB Z, POURNAZARI P, SHELDON R S. What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and Meta-analysis[J]. J Atr Fibrillation, 2018, 10(6): 1870.
[18] FUMAGALLI S, POTPARA T S, BJERREGAARD LARSEN T, et al. Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey[J]. Europace, 2017, 19(11): 1896-1902.
[19] SZE S, PELLICORI P, ZHANG J, et al. Identification of Frailty in Chronic Heart Failure[J]. JACC Heart Fail, 2019, 7(4): 291-302.
[20] DENFELD Q E, WINTERS-STONE K, MUDD J O, et al. The prevalence of frailty in heart failure: a systematic review and meta-analysis[J]. Int J Cardiol, 2017, 236(6): 283-289.
[21] BENJAMIN E J, VIRANI S S, CALLAWAY C W, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association[J]. Circulation, 2018, 137(12): e67-e492.
[22] LEE D H, BUTH K J, MARTIN B J, et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery[J]. Circulation, 2010, 121(8): 973-978.
[23] SÜNDERMANN S, DADEMASCH A, PRAETORIUS J, et al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery[J]. Eur J Cardiothorac Surg, 2011, 39(1): 33-37.
[24] AFILALO J, MOTTILLO S, EISENBERG M J, et al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity[J]. Circ Cardiovasc Qual Outcomes, 2012, 5(2): 222-228.
[25] STEWART R. Cardiovascular disease and frailty: what are the mechanistic links?[J]. Clin Chem, 2019, 65(1): 80-86.
[26] AREM H, MOORE SC, PATEL A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship[J]. JAMA Intern Med, 2015, 175(6): 959-967.
[27] STEWART R A H, HELD C, HADZIOSMANOVIC N, et al. Physical activity and mortality in patients with stable coronary heart disease[J]. J Am Coll Cardiol, 2017, 70(14): 1689-1700.
[28] SRINIVAS-SHANKAR U, ROBERTS S A, CONNOLLY M J, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study[J]. J Clin Endocrinol Metab, 2010, 95(2): 639-650.
[29] SHARDELL M, D’ADAMO C, ALLEY D E, et al. Serum 25-hydroxyvitamin D, transitions between frailty states, and mortality in older adults: the Invecchiare in Chianti Study[J]. J Am Geriatr Soc, 2012, 60(2): 256-264.
[30] FERRUCCI L, FABBRI E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty[J]. Nat Rev Cardiol, 2018, 15(9): 505-522.
[31] MOADDEL R, FABBRI E, KHADEER M A, et al. Plasma biomarkers of poor muscle quality in older men and women from the Baltimore Longitudinal Study of Aging[J]. J Gerontol A Biol Sci Med Sci, 2016, 71(10): 1266-1272.
[32] MUN H, LIU B, PHAM T H A, et al. C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches[J]. Osteoporos Int, 2021, 32(3): 425-435.
[33] LENG S, CHAVES P, KOENIG K, et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study[J]. J Am Geriatr Soc, 2002, 50(7): 1268-1271.
[34] DING C, PARAMESWARAN V, UDAYAN R, et al. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study[J]. J Clin Endocrinol Metab, 2008, 93(5): 1952-1958.
[35] IJAZ N, BUTA B, XUE Q L, et al. Interventions for frailty among older adults with cardiovascular disease: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2022, 79(5): 482-503.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	. [J]. Practical Geriatrics, 2024, 38(10): 979-982.
[2]	GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029.
[3]	LIU Jin, HUANG Yanqiu, ZHU Yi, ZHUO Lili. Effects of sacubitril valsartan sodium in elderly patients with chronic heart failure [J]. Practical Geriatrics, 2024, 38(10): 1030-1033.
[4]	XU Shouyong, YUAN Yong. Study on feasibility of dual-low-dose CT coronary angiography in elderly patients [J]. Practical Geriatrics, 2024, 38(10): 1054-1058.
[5]	LIU Lin, WU Qing, ZHANG Jing, MAO Fangying, YU Lu, REN Yiting, FANG Ting. Status and influencing factors of symptom perception in elderly patients with heart failure [J]. Practical Geriatrics, 2024, 38(5): 461-437.
[6]	LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437.
[7]	ZHANG Lili, LI Jing, DING Linfeng, SUN Jingxian, CAI Jingbo. Predictive value of carotid atherosclerosis plaque for ischemic stroke events in patients with nonvalvular atrial fibrillation [J]. Practical Geriatrics, 2024, 38(3): 236-239.
[8]	ZHA Zhimin, LIU Huan, WANG Xiangming, LI Qiushuang, GUO Yan. Effect of cardiac valve calcification on prognosis of elderly patients with coronary heart disease [J]. Practical Geriatrics, 2024, 38(3): 245-250.
[9]	. [J]. Practical Geriatrics, 2024, 38(3): 308-311.
[10]	CHENG Qing, XU Yan, CHEN Guofei, DENG Xinyue. Correlation of serum angiotensin Ⅱ and nitric oxide levels with cognitive dysfunction in elderly patients with chronic heart failure [J]. Practical Geriatrics, 2024, 38(2): 132-135.
[11]	ZHANG Ying, XIE Ling, YE Jiaqi, QIANG Wenhui, YAN Xiaoyun, JIANG Ying, ZHANG Qing. Correlation between laminin and major adverse cardiovascular events in elderly patients with acute myocardial infarction [J]. Practical Geriatrics, 2024, 38(2): 149-151.
[12]	REN Li-yan. Correlation between serum cholinesterase and ventricular remodeling in elderly patients with heart failure [J]. Practical Geriatrics, 2023, 37(12): 1238-1241.
[13]	. [J]. Practical Geriatrics, 2023, 37(12): 1270-1273.
[14]	LU Hao, DENG Hui, WANG Chun, DAI Yang, WANG Qin, WANG Qing. Characteristics of cardiopulmonary function, exercise endurance, and the levels of NT-proBNP and TNT in elderly patients with stable chronic heart failure [J]. Practical Geriatrics, 2023, 37(11): 1138-1142.
[15]	YANG Xue, NING Chun, ZHAO Juan, HAO Jing-bo, YANG Rong-li. Diagnostic value of growth differentiation factor 15 and cytokines in elderly patients with coronary heart disease complicated with frailty [J]. Practical Geriatrics, 2023, 37(10): 1009-1013.